Tracking Duchenne muscular dystrophy over time
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study is building a registry of people with Duchenne muscular dystrophy to learn more about how the condition develops over time, which can help improve future care and research. If you join, your health information will be collected during your regular clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed genetic diagnosis of Duchenne muscular dystrophy.
- You must be receiving care at one of the four participating medical centers.
- You must sign a consent form agreeing to take part.
- You cannot take part if you choose not to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a national registry for people with Duchenne muscular dystrophy in the UK. It collects routine health data to help research and improve care, without requiring any extra tests or procedures.
This study follows boys with Duchenne muscular dystrophy over time to better understand how the condition changes and how standard treatments affect health and function. It does not appear to test a new medicine, but it may help doctors plan better future care and studies.
This is a research study that follows people with Duchenne muscular dystrophy and female genetic carriers to better understand the condition. It may help researchers measure health patterns over time, which can support future treatments.
This registry collects information about people with Duchenne or Becker muscular dystrophy, including women who carry the gene (with or without symptoms). It may help researchers better understand the condition and plan future studies.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
Hear when a new Duchenne Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.